Furthermore, TGF-β levels were significantly higher among those with moderate and mild fibrosis (F2-F3) regardless of the inflammation, suggesting the role TGF-β in HCV patients takes place mostly in earlier stages of the disease before cirrhosis is well established [34]. Here, TGFB1 is linked to fibrosis.